Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Lannett Company, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Lannett Company, Inc. with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
Lannett Company, Inc.
Package NDC
0527-4662-37
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.